Feeds

US Supremes: Human genes can't be patented

It's not quite that simple, of course – but is it ever?

Boost IT visibility and business value

In a welcome display of patent-law sanity, the US Supreme Court has unanimously ruled that human genes can't be patented.

"We hold that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated," wrote Justice Clarence Thomas, who authored the court's decision.

The decision puts into question patents that were the subject of the case, and which are held by Myriad Genetic Laboratories of Salt Lake City, Utah. Those patents protect the company's BRACAnalysis hereditary breast-cancer probability test – a positive result from which having recently motivated actress Angelina Jolie to undergo a double mastectomy.

"Myriad did not create anything," Thomas wrote. "To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention."

Interestingly, Myriad's stock price jumped by over 10 per cent on the news. Apparently investors were buouyed by the fact that the opinion banned the patenting of isolated human genes, but not synthetic DNA – also known as complementary DNA, or cDNA.

As Thomas wrote in his ruling, "cDNA is patent eligible because it is not naturally occurring."

Myriad president and CEO Peter Meldrum was pleased with that distinction. "We believe the Court appropriately upheld our claims on cDNA, and underscored the patent eligibility of our method claims, ensuring strong intellectual property protection for our BRACAnalysis test moving forward," he wrote in a press release.

Apparently Myriad's investors were sufficiently mollified, seeing as how the company's stock hit a four-year high.

Despite the patentability of cDNA, the unanimous decision is a victory for researchers, geneticists, and cancer patients who argued that a single company holding a patent on a gene could raise test and treatment costs, and stifle research.

"It is splendid news for patients, for physicians, for scientists and for common sense," geneticist Mary-Claire King told USA Today. "The marketplace will now be open."

Exactly how open remains to be seen, but it is clear from the decision that your "naturally occurring" genes are now safe from corporate control. ®

Build a business case: developing custom apps

More from The Register

next story
Hello, police, El Reg here. Are we a bunch of terrorists now?
Do Brits risk arrest for watching beheading video nasty? We asked the fuzz
Munich considers dumping Linux for ... GULP ... Windows!
Give a penguinista a hug, the Outlook's not good for open source's poster child
Detroit losing MILLIONS because it buys CHEAP BATTERIES – report
Man at hardware store was right: name brands DO last longer
Snowden on NSA's MonsterMind TERROR: It may trigger cyberwar
Plus: Syria's internet going down? That was a US cock-up
UK government accused of hiding TRUTH about Universal Credit fiasco
'Reset rating keeps secrets on one-dole-to-rule-them-all plan', say MPs
Caught red-handed: UK cops, PCSOs, specials behaving badly… on social media
No Mr Fuzz, don't ask a crime victim to be your pal on Facebook
e-Borders fiasco: Brits stung for £224m after US IT giant sues UK govt
Defeat to Raytheon branded 'catastrophic result'
Yes, but what are your plans if a DRAGON attacks?
Local UK gov outs most ridiculous FoI requests...
EU justice chief blasts Google on 'right to be forgotten'
Don't pretend it's a freedom of speech issue – interim commish
This'll end well: US govt says car-to-car jibber-jabber will SAVE lives
Department of Transportation starts cogs turning for another wireless comms standard
prev story

Whitepapers

Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Top 10 endpoint backup mistakes
Avoid the ten endpoint backup mistakes to ensure that your critical corporate data is protected and end user productivity is improved.
Top 8 considerations to enable and simplify mobility
In this whitepaper learn how to successfully add mobile capabilities simply and cost effectively.
Rethinking backup and recovery in the modern data center
Combining intelligence, operational analytics, and automation to enable efficient, data-driven IT organizations using the HP ABR approach.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.